Finance

Lists
2VJ:FRA
Ascletis Pharma Inc
€1.10
-0.90%
(-0.0100) 1D
Sep 4, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 2VJ...
Open
€1.10
High
€1.11
Low
€1.10
Mkt. cap
10.61B
Avg. vol.
46.00
Volume
0.00
52-wk high
€2.06
52-wk low
€0.91
No. of employees
202
Open
€1.10
High
€1.11
Low
€1.10
Mkt. cap
10.61B
Avg. vol.
46.00
Volume
0.00
52-wk high
€2.06
52-wk low
€0.91
No. of employees
202
About Ascletis Pharma Inc
CEO-
Employees202
Founded2013
Headquarters-
SectorBiotechnology
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
473.50K
473.50K
-
-
Cost of goods sold
270.50K
270.50K
-
-
Cost of revenue
270.50K
270.50K
-
-
Research and development expenses
131.12M
131.12M
170.83M
170.83M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
15.96M
15.96M
15.40M
15.40M
Operating expense
147.29M
147.29M
159.75M
159.75M
Total operating expenses
147.56M
147.56M
159.75M
159.75M
Operating income
-147.09M
-147.09M
-159.75M
-159.75M
Other non operating income
1.86M
1.86M
-
-
EBT including unusual items
-135.71M
-135.71M
-159.79M
-159.79M
EBT excluding unusual items
-129.84M
-129.84M
-159.79M
-159.79M
Income tax expense
253.00K
253.00K
49.00K
49.00K
Effective tax rate
-0.19%
-0.19%
-0.03%
-0.03%
Other operating expenses
203.50K
203.50K
-26.48M
-26.48M
Net income
-135.96M
-135.96M
-159.84M
-159.84M
Net profit margin
-28,714.78%
-28,714.78%
-
-
Earnings per share
-
-
-
-
Interest and investment income
17.60M
17.60M
-
-
Interest expense
-38.50K
-38.50K
-37.00K
-37.00K
Net interest expenses
17.57M
17.57M
-37.00K
-37.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-144.36M
-144.36M
-156.71M
-156.71M
Gain or loss from assets sale
-13.26M
-13.26M
-
-
AI content may include mistakes. Learn more
Google apps